Literature DB >> 1312469

Technetium-99m diethylene triamine penta-acetic acid and dimercaptosuccinic acid in the detection of a segmental branch stenosis of the renal artery by captopril renography.

L Bajnok1, J Varga, G Kurta.   

Abstract

We present a case in which a 39-year-old woman with correctable bilateral renovascular hypertension did not show abnormality during post-captopril technetium-99m dimercaptosuccinic acid (DMSA) study. Post-captopril 99mTc-diethylene triamine penta-acetic acid (DTPA) scintigraphy revealed the adverse effect of a stenosis of the artery supplying the upper part of her left kidney but failed to uncover the existence of severe multiple narrowings of the right renal artery. After bilateral renovascular reconstructive surgery, the hypertension completely disappeared. This case illustrates that DTPA may be more efficacious than DMSA in the detection of segmental loss of renal function induced by angiotensin converting enzyme inhibition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312469     DOI: 10.1007/bf00178309

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  7 in total

1.  Diagnostic use of angiotensin converting enzyme inhibitors in radioisotope evaluation of unilateral renal artery stenosis.

Authors:  T K Kremer Hovinga; P E de Jong; D A Piers; H Beekhuis; G K van der Hem; D de Zeeuw
Journal:  J Nucl Med       Date:  1989-05       Impact factor: 10.057

2.  Reversible diminished renal 99mTc-DMSA uptake during converting-enzyme inhibition in a patient with renal artery stenosis.

Authors:  T K Hovinga; J R Beukhof; W H van Luyk; D A Piers; A J Donker
Journal:  Eur J Nucl Med       Date:  1984

3.  Renal scintigraphic captopril test in the diagnosis of renovascular hypertension.

Authors:  E Fommei; S Ghione; L Palla; F Mosca; M Ferrari; C Palombo; S Giaconi; P Gazzetti; L Donato
Journal:  Hypertension       Date:  1987-08       Impact factor: 10.190

4.  Single-dose captopril scintigraphy in the diagnosis of renovascular hypertension.

Authors:  G N Sfakianakis; J J Bourgoignie; D Jaffe; G Kyriakides; E Perez-Stable; R C Duncan
Journal:  J Nucl Med       Date:  1987-09       Impact factor: 10.057

5.  Renovascular hypertension identified by captopril-induced changes in the renogram.

Authors:  G G Geyskes; H Y Oei; C B Puylaert; E J Mees
Journal:  Hypertension       Date:  1987-05       Impact factor: 10.190

6.  Captopril renal scintigraphy in a patient with bilateral renal artery stenosis.

Authors:  K Itoh; M Shinohara; M Togashi; T Koyanagi
Journal:  J Nucl Med       Date:  1989-12       Impact factor: 10.057

7.  Evaluation of hypertensive patients by means of captopril enhanced renal scintigraphy with technetium-99m DTPA.

Authors:  M Dondi; R Franchi; M Levorato; A Zuccalà; R Gaggi; M Mirelli; A Stella; F Marchetta; F Losinno; N Monetti
Journal:  J Nucl Med       Date:  1989-05       Impact factor: 10.057

  7 in total
  2 in total

Review 1.  The diagnosis of renovascular hypertension: the role of captopril renal scintigraphy and related issues.

Authors:  A Prigent
Journal:  Eur J Nucl Med       Date:  1993-07

2.  Hypertension in paediatrics: can pre- and post-captopril technetium-99m dimercaptosuccinic acid renal scans exclude renovascular disease?

Authors:  I Minty; M F Lythgoe; I Gordon
Journal:  Eur J Nucl Med       Date:  1993-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.